According to Merck's latest financial reports the company's total liabilities are $63.10 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $63.10 B | -6.43% |
2021-12-31 | $67.43 B | 1.89% |
2020-12-31 | $66.18 B | 13.34% |
2019-12-31 | $58.39 B | 4.74% |
2018-12-31 | $55.75 B | 4.6% |
2017-12-31 | $53.30 B | -3.21% |
2016-12-31 | $55.06 B | -3.41% |
2015-12-31 | $57.01 B | 15.07% |
2014-12-31 | $49.54 B | -7.08% |
2013-12-31 | $53.31 B | 5.23% |
2012-12-31 | $50.66 B | 5.16% |
2011-12-31 | $48.18 B | -1.62% |
2010-12-31 | $48.97 B | -3.2% |
2009-12-31 | $50.59 B | 94.39% |
2008-12-31 | $26.02 B | -6.23% |
2007-12-31 | $27.75 B | 12.82% |
2006-12-31 | $24.60 B | 0.33% |
2005-12-31 | $24.52 B | 7.19% |
2004-12-31 | $22.87 B | 8.45% |
2003-12-31 | $21.09 B | -13.66% |
2002-12-31 | $24.43 B | 5.68% |
2001-12-31 | $23.11 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $110.57 B | 75.23% | ๐บ๐ธ USA |
![]() Novartis NVS | $60.09 B | -4.76% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $101.28 B | 60.52% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $37.53 B | -40.52% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $41.86 B | -33.65% | ๐บ๐ธ USA |
![]() Amgen AMGN | $83.37 B | 32.12% | ๐บ๐ธ USA |
![]() Sanofi SNY | $55.23 B | -12.47% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $62.39 B | -1.12% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $58.57 B | -7.18% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $35.31 B | -44.04% | ๐ฎ๐ฑ Israel |